Status:
TERMINATED
Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders
Lead Sponsor:
Vida Recoletas Sevilla
Collaborating Sponsors:
Instituto Valenciano de Infertilidad, IVI VALENCIA
IVI Madrid
Conditions:
Infertility
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
A randomised, crossover, multicentre, national, clinical trial comparing the efficacy of corifollitropin alfa versus daily recombinant FSH and HMG in the controlled ovarian stimulation of women with a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Advanced maternal age (≥40 years)
- A previous poor ovarian response (≤3 oocytes with a conventional stimulation protocol)
- An abnormal ovarian reserve test (i.e. antral follicle count \<5-7 follicles or anti-mullerian hormone level \<0.5-1.1 ng/ml)
Exclusion
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT02254928
Start Date
September 1 2014
End Date
November 1 2015
Last Update
January 18 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Barcelona
Barcelona, Barcelona, Spain, 08017
2
IVI Madrid
Madrid, Madrid, Spain, 28023
3
IVI Sevilla
Seville, Seville, Spain, 41006
4
IVI Valencia
Valencia, Valencia, Spain, 46015